American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic determinants of clonal hematopoiesis and progression to hematologic malignancies in 479,117 individuals
    Meeting Abstract

    Liu, J.; Tran, D.; Chan, I. C. C.; Wiley, B.; Watson, C.; Batchi-Bouyou, A. L.; Zong, X.; Stopsack, K. H.; Pharoah, P.; Ding, L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clonal hematopoiesis is common in unrelated stem cell donors but has no impact on patient outcome after hematopoietic stem cell transplantation
    Meeting Abstract

    Schetelig, J.; Damm, F.; Günther, U. P.; Baldauf, H.; Rave, C.; Koster, L.; Schöfl, G.; Klussmeier, A.; Menghrajani, K.; Bolton, K. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Plasma circulating tumor DNA (ctDNA) as an alternative to tissue DNA for genotyping of DLBCL: Results from the POLARIX study
    Meeting Abstract

    Jardin, F.; Raghavan, V.; Tracy, S.; Balasubramanian, S.; Sehn, L. H.; Flowers, C. R.; Morschhauser, F.; Herrera, A. F.; Trněný, M.; Sharman, J. P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The early benefits and psychological effects of screening for monoclonal gammopathy of undetermined significance: Results of the Istopmm study
    Meeting Abstract

    Rögnvaldsson, S.; Thorsteinsdottir, S.; Oskarsson, J.; Eythorsson, E.; Sigurdardottir, G. A.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B.; Sigurdardottir, M.; Olafsson, I.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Early and consistent CRS detection using wearable device for remote patient monitoring following CAR-T therapy in relapsed/refractory multiple myeloma (RRMM): Early results of an investigator-initiated trial
    Meeting Abstract

    Rajeeve, S.; Zahradka, N.; Wilkes, M.; Pan, D.; Calafat, N. J.; Serebryakova, K.; Kappes, K.; Jackson, H.; Buchenholz, N.; Agte, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of dexamethasone (Dex) dose strength on outcomes in newly diagnosed multiple myeloma (NDMM): A Secondary analysis of SWOG Studies S0777 and S1211
    Meeting Abstract

    Banerjee, R.; Sexton, R.; Cowan, A. J.; Ailawadhi, S.; Rajkumar, S. V.; Kumar, S. K.; Lonial, S.; Barlogie, B.; Durie, B. G. M.; Usmani, S. Z.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The dual inflammasome/myddosome inhibitor HT-6184 restores erythropoiesis in MDS/AML
    Meeting Abstract

    Rabinovich, E.; Fromowitz, A.; Ajibade, O.; Sahu, S.; Verma, D.; Aminov, S.; Ramachandra, N.; Selverian, C.; Khalizova, N.; Aluri, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • PD-1 blockade before autologous stem cell transplantation improves outcomes in relapsed/refractory classic Hodgkin lymphoma: Results from a multicenter cohort
    Meeting Abstract

    Desai, S. H.; Merryman, R. W.; Shah, H.; Pederson, L. D.; Geyer, S. M.; Ganesan, N.; Chang, T.; Othman, T.; Falade, A. S.; Shah, G. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Performance of positron emission tomography at diagnosis and response assessment in low and intermediate-risk nodular lymphocyte predominant Hodgkin lymphoma
    Meeting Abstract

    Marks, L. J.; McCarten, K.; Pei, Q.; Wu, Y.; Kelly, K. M.; Schwartz, C.; Wolden, S.; Friedman, D. L.; Castellino, S. M.; Appel, B.
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of mutations in blood cancer-related genes on clinical outcomes in chronic myeloid leukemia in chronic phase (CML-CP) after ≥2 tyrosine kinase inhibitors ( TKIs) in the Ascembl trial
    Meeting Abstract

    Branford, S.; Hochhaus, A.; Mauro, M.; Minami, Y.; Rea, D.; Freitas, Cmbd; Serrano-Fernandez, P.; Obourn, V.; Bruederle, A.; Espurz, N.; more...
    Blood (2023)

    Fulltext@MSK | Save